Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,325 warrant series at 1,053 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BriaCell Legacy Warrants ($928.50, expiring December 7, 2026) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| December 2024 Representative's Warrants ($140.63) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| December 2024 Warrants ($140.63) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| February 2025 Placement Agent Warrants ($50.00) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| January 2026 Placement Agent Warrants ($8.39) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| January 2026 Warrants (BCTXL, $6.93) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| July 2025 Warrants ($15.00) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| June 2026 Placement Agent Warrants ($4.06) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| May 2024 Offering Warrants ($316.50) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| May 2024 Placement Agent Warrants ($348.00) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| October 2024 Placement Agent Warrants ($182.81) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| October 2024 Warrants ($127.50) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| September 2024 Placement Agent Warrants ($129.38) | $3.51 | $30.7M | 10-K, Oct 28, 2026Dilution tabAs of Oct 28, 2026 | ||||||||
| 2023 Private Warrants | $0.2218 | $30.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2023 Promissory Notes Warrants | $0.2218 | $30.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2023 Registered Direct Offering Placement Agent Warrants | $0.2218 | $30.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 Underwriting Agreement Warrants (December 2025) | $0.2218 | $30.5M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| PIPE Pre-Funded Warrants (December 2025 Private Placement) | $2.76 | $30.4M | 10-Q, Aug 14, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| PIPE Series A Common Warrants (December 2025 Private Placement) | $2.76 | $30.4M | 10-Q, Aug 14, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| PIPE Series B Common Warrants (December 2025 Private Placement) | $2.76 | $30.4M | 10-Q, Aug 14, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| Sermonix Pre-Funded Warrant (Sermonix License consideration) | $2.76 | $30.4M | 10-Q, Aug 14, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| May 2022 registered direct warrants ($2.20; investor and placement-agent warrants combined) | $4.26 | $30.1M | 20-F, Mar 31, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| April 2024 Warrants (remaining after June 2026 inducement, $1.95) | $0.9600 | $29.7M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| October 2026 Common Warrants (private placement, $1.65) | $0.9600 | $29.7M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| September 2024 Warrants ($6.40) | $0.9600 | $29.7M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| SVB Warrants (lender warrants, June 2021 loan) | $0.9600 | $29.7M | 10-Q, Nov 5, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| August 2026 Common Warrants ($4.60) | $0.3415 | $29.7M | 6-K, Aug 28, 2026Dilution tabAs of Oct 14, 2026 | ||||||||
| October 13, 2026 Common Warrants ($1.00) | $0.3415 | $29.7M | 424B5, Oct 13, 2026Dilution tabAs of Oct 14, 2026 | ||||||||
| October 13, 2026 Pre-Funded Warrants ($0.04) | $0.3415 | $29.7M | 424B5, Oct 13, 2026Dilution tabAs of Oct 14, 2026 | ||||||||
| October 7, 2026 Common Warrants ($1.35) | $0.3415 | $29.7M | 6-K, Oct 13, 2026Dilution tabAs of Oct 14, 2026 | ||||||||
| October 9, 2026 Common Warrants ($1.00) | $0.3415 | $29.7M | 6-K, Oct 13, 2026Dilution tabAs of Oct 14, 2026 | ||||||||
| July 2026 Common Warrants | $1.16 | $29.6M | 8-K, Jul 30, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| May 2026 Common Warrants | $1.16 | $29.6M | 8-K, May 20, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2025 Series A Common Stock Purchase Warrants | $1.16 | $29.6M | 8-K, Nov 14, 2025Dilution tabAs of Nov 17, 2026 | ||||||||
| November 2025 Series B Common Stock Purchase Warrants | $1.16 | $29.6M | 8-K, Nov 14, 2025Dilution tabAs of Nov 17, 2026 | ||||||||
| Scientific Advisory Board Warrants granted August 2026 | $1.16 | $29.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Scientific Advisory Board Warrants granted fiscal year ended June 30, 2024 | $1.16 | $29.6M | 10-K, Sep 28, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Scientific Advisory Board Warrants granted fiscal year ended June 30, 2025 | $1.16 | $29.6M | 10-K, Sep 28, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Scientific Advisory Board Warrants granted fiscal year ended June 30, 2026 | $1.16 | $29.6M | 10-K, Sep 28, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Warrants expiring in fiscal year ending June 30, 2027 | $1.16 | $29.6M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Pre-funded warrants issued in voluntary exchange (September 2026) | $4.86 | $29.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Warrants outstanding per 10-Q warrant table (aggregate, excluding pre-funded warrants) | $4.86 | $29.4M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| MGMH Warrant – Amendment No. 3 (750,000 shares, $10.00) | $1.90 | $29.0M | SCHEDULE 13D/A, Aug 25, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| MGMH Warrant – Omnibus Amendment No. 2 (750,000 shares, $10.00) | $1.90 | $29.0M | SCHEDULE 13D/A, Aug 25, 2026Dilution tabAs of Nov 2, 2026 | ||||||||
| IPO Underwriter (Representative) Warrants — $14.375, expiring December 13, 2026 | $0.5770 | $28.9M | 20-F, Apr 1, 2026Dilution tabAs of Oct 4, 2026 | ||||||||
| August 2023 PIPE Common Warrants ($43.75) | $3.21 | $28.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2026 PIPE Common Share Warrants ($14.40) | $3.21 | $28.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2026 PIPE Pre-Funded Warrants ($0.0001) | $3.21 | $28.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| July 2024 PIPE Tranche B Warrants ($50.50) | $3.21 | $28.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| July 2024 PIPE Tranche C Warrants ($62.50) | $3.21 | $28.9M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 |
BCTXBriaCell Therapeutics Corp.$3.51Last price
BriaCell Legacy Warrants ($928.50, expiring December 7, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
December 2024 Representative's Warrants ($140.63)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
December 2024 Warrants ($140.63)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
February 2025 Placement Agent Warrants ($50.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
January 2026 Placement Agent Warrants ($8.39)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
January 2026 Warrants (BCTXL, $6.93)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
July 2025 Warrants ($15.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
June 2026 Placement Agent Warrants ($4.06)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
May 2024 Offering Warrants ($316.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
May 2024 Placement Agent Warrants ($348.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
October 2024 Placement Agent Warrants ($182.81)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
October 2024 Warrants ($127.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
BCTXBriaCell Therapeutics Corp.$3.51Last price
September 2024 Placement Agent Warrants ($129.38)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.7M
REKRRekor Systems, Inc.$0.2218Last price
2023 Private Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.5M
REKRRekor Systems, Inc.$0.2218Last price
2023 Promissory Notes Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.5M
REKRRekor Systems, Inc.$0.2218Last price
2023 Registered Direct Offering Placement Agent Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.5M
REKRRekor Systems, Inc.$0.2218Last price
2025 Underwriting Agreement Warrants (December 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.5M
LONALeonaBio, Inc.$2.76Last price
PIPE Pre-Funded Warrants (December 2025 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.4M
LONALeonaBio, Inc.$2.76Last price
PIPE Series A Common Warrants (December 2025 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.4M
LONALeonaBio, Inc.$2.76Last price
PIPE Series B Common Warrants (December 2025 Private Placement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.4M
LONALeonaBio, Inc.$2.76Last price
Sermonix Pre-Funded Warrant (Sermonix License consideration)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.4M
BOSCB.O.S. Better On-Line Solutions Ltd.$4.26Last price
May 2022 registered direct warrants ($2.20; investor and placement-agent warrants combined)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$30.1M
INMBINmune Bio, Inc.$0.9600Last price
April 2024 Warrants (remaining after June 2026 inducement, $1.95)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
INMBINmune Bio, Inc.$0.9600Last price
October 2026 Common Warrants (private placement, $1.65)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
INMBINmune Bio, Inc.$0.9600Last price
September 2024 Warrants ($6.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
INMBINmune Bio, Inc.$0.9600Last price
SVB Warrants (lender warrants, June 2021 loan)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
MINFT Limited$0.3415Last price
August 2026 Common Warrants ($4.60)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
MINFT Limited$0.3415Last price
October 13, 2026 Common Warrants ($1.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
MINFT Limited$0.3415Last price
October 13, 2026 Pre-Funded Warrants ($0.04)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
MINFT Limited$0.3415Last price
October 7, 2026 Common Warrants ($1.35)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
MINFT Limited$0.3415Last price
October 9, 2026 Common Warrants ($1.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.7M
NNVCNanoViricides, Inc.$1.16Last price
July 2026 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
May 2026 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
November 2025 Series A Common Stock Purchase Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
November 2025 Series B Common Stock Purchase Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
Scientific Advisory Board Warrants granted August 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
Scientific Advisory Board Warrants granted fiscal year ended June 30, 2024
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
Scientific Advisory Board Warrants granted fiscal year ended June 30, 2025
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
Scientific Advisory Board Warrants granted fiscal year ended June 30, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
NNVCNanoViricides, Inc.$1.16Last price
Warrants expiring in fiscal year ending June 30, 2027
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.6M
CRTDCreatd, Inc.$4.86Last price
Pre-funded warrants issued in voluntary exchange (September 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.4M
CRTDCreatd, Inc.$4.86Last price
Warrants outstanding per 10-Q warrant table (aggregate, excluding pre-funded warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.4M
WKHSWorkhorse Group Inc.$1.90Last price
MGMH Warrant – Amendment No. 3 (750,000 shares, $10.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.0M
WKHSWorkhorse Group Inc.$1.90Last price
MGMH Warrant – Omnibus Amendment No. 2 (750,000 shares, $10.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$29.0M
SAENGenenta Science S.p.A. American Depositary Shares$0.5770Last price
IPO Underwriter (Representative) Warrants — $14.375, expiring December 13, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$28.9M
PMNProMIS Neurosciences, Inc.$3.21Last price
August 2023 PIPE Common Warrants ($43.75)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$28.9M
PMNProMIS Neurosciences, Inc.$3.21Last price
January 2026 PIPE Common Share Warrants ($14.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$28.9M
PMNProMIS Neurosciences, Inc.$3.21Last price
January 2026 PIPE Pre-Funded Warrants ($0.0001)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$28.9M
PMNProMIS Neurosciences, Inc.$3.21Last price
July 2024 PIPE Tranche B Warrants ($50.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$28.9M
PMNProMIS Neurosciences, Inc.$3.21Last price
July 2024 PIPE Tranche C Warrants ($62.50)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$28.9M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,066 dilution snapshots. 4,872 of 5,325 series state an exercise price and 3,364 an expiry date. 184 record when exercise begins; that count grows as companies are re-extracted. 623 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.